Fish oil feeding attenuates neuroinflammatory gene expression without concomitant changes in brain eicosanoids and docosanoids in a mouse model of Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Brain, behavior, and immunity

• Publication date

  2017-11-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbi.2017.11.002PMID 29109025
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular imaging of neuroinflammation in Alzheimer's disease and mild cognitive impairment

  2018cited by this paper
• Markers of microglia in post-mortem brain samples from patients with Alzheimer’s disease: a systematic review

  2017cited by this paper
• Tert-butylhydroquinone protects PC12 cells against ferrous sulfate-induced oxidative and inflammatory injury via the Nrf2/ARE pathway.

  2017cited by this paper
• Maternal dietary n-6 polyunsaturated fatty acid deprivation does not exacerbate post-weaning reductions in arachidonic acid and its mediators in the mouse hippocampus

  2017cited by this paper
• High‐resolution lipidomics coupled with rapid fixation reveals novel ischemia‐induced signaling in the rat neurolipidome

  2017cited by this paper
• Dietary fish oil, and to a lesser extent the fat-1 transgene, increases astrocyte activation in response to intracerebroventricular amyloid-β 1–40 in mice

  2017cited by this paper
• Dietary Linoleic Acid Lowering Reduces Lipopolysaccharide-Induced Increase in Brain Arachidonic Acid Metabolism

  2016cited by this paper
• Brain omega-3 polyunsaturated fatty acids modulate microglia cell number and morphology in response to intracerebroventricular amyloid-β 1-40 in mice

  2016cited by this paper
• N-3 polyunsaturated fatty acids in animal models with neuroinflammation: An update.

  2016cited by this paper
• Lowering dietary n-6 polyunsaturated fatty acids: interaction with brain arachidonic and docosahexaenoic acids

  2016cited by this paper
• Resolution of inflammation is altered in Alzheimer's disease

  2015cited by this paper
• Resolvins AT-D1 and E1 differentially impact functional outcome, post-traumatic sleep, and microglial activation following diffuse brain injury in the mouse.

  2015cited by this paper
• Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD study[S]

  2015cited by this paper
• ω‐3 Supplementation increases amyloid‐β phagocytosis and resolvin D1 in patients with minor cognitive impairment

  2015cited by this paper
• Intakes of fish and polyunsaturated fatty acids and mild-to-severe cognitive impairment risks: a dose-response meta-analysis of 21 cohort studies.

  2015cited by this paper
• Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis

  2015cited by this paper
• Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains

  2015cited by this paper
• Resolvin D2 recovers neural injury by suppressing inflammatory mediators expression in lipopolysaccharide-induced Parkinson's disease rat model.

  2015cited by this paper
• Chronic dietary n-6 PUFA deprivation leads to conservation of arachidonic acid and more rapid loss of DHA in rat brain phospholipids[S]

  2015cited by this paper
• Inhibiting Mitochondrial β-Oxidation Selectively Reduces Levels of Nonenzymatic Oxidative Polyunsaturated Fatty Acid Metabolites in the Brain

  2014cited by this paper
• Polyunsaturated fatty acids and their metabolites in brain function and disease

  2014cited by this paper
• Enriched endogenous omega-3 fatty acids in mice protect against global ischemia injury

  2014cited by this paper
• Neuropathological Responses to Chronic NMDA in Rats Are Worsened by Dietary n-3 PUFA Deprivation but Are Not Ameliorated by Fish Oil Supplementation

  2014cited by this paper
• Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue.

  2014cited by this paper
• Pro-resolving lipid mediators are leads for resolution physiology

  2014cited by this paper
• Comprehensive ultra-performance liquid chromatographic separation and mass spectrometric analysis of eicosanoid metabolites in human samples.

  2014cited by this paper
• TREM2 variants in Alzheimer's disease.

  2013cited by this paper
• Aspirin‐triggered resolvin D1 prevents surgery‐induced cognitive decline

  2013cited by this paper
• Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein/tau for Alzheimer’s disease

  2013cited by this paper
• Whole body synthesis rates of DHA from α-linolenic acid are greater than brain DHA accretion and uptake rates in adult rats[S]

  2013cited by this paper
• Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.

  2013cited by this paper
• Iodine and Mental Development of Children 5 Years Old and Under: A Systematic Review and Meta-Analysis

  2013cited by this paper
• Neuroprotective Effect of Physical Exercise in a Mouse Model of Alzheimer’s Disease Induced by β-Amyloid1–40 Peptide

  2013cited by this paper
• Microsomal prostaglandin E synthase‐1 is induced in alzheimer's disease and its deletion mitigates alzheimer's disease‐like pathology in a mouse model

  2013cited by this paper
• CD33 Alzheimer’s disease locus: Altered monocyte function and amyloid biology

  2013cited by this paper
• FcγRIIb mediates amyloid-β neurotoxicity and memory impairment in Alzheimer's disease.

  2013cited by this paper
• Neuroinflammation and Neuronal Loss Precede Aβ Plaque Deposition in the hAPP-J20 Mouse Model of Alzheimer’s Disease

  2013cited by this paper
• Unesterified docosahexaenoic acid is protective in neuroinflammation

  2013cited by this paper
• 1α,25-Dihydroxyvitamin D3 and Resolvin D1 Retune the Balance between Amyloid-β Phagocytosis and Inflammation in Alzheimer's Disease Patients

  2013cited by this paper
• ω-3 fatty acids in the prevention of cognitive decline in humans.

  2013cited by this paper
• Sequence variants of interleukin 6 (IL-6) are significantly associated with a decreased risk of late-onset Alzheimer's disease

  2012cited by this paper
• Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study

  2012cited by this paper
• Sequence Variants of Toll Like Receptor 4 and Late-Onset Alzheimer's Disease

  2012cited by this paper
• Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease–like pathology and cognitive decline

  2012cited by this paper
• Ethyl-eicosapentaenoate (E-EPA) attenuates motor impairments and inflammation in the MPTP-probenecid mouse model of Parkinson's disease.

  2012cited by this paper
• Tumor necrosis factor-α synthesis inhibitor 3,6′-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer’s disease

  2012cited by this paper
• Novel aspirin-triggered neuroprotectin D1 attenuates cerebral ischemic injury after experimental stroke.

  2012cited by this paper
• The Effects of Long-Term Omega-3 Fatty Acid Supplementation on Cognition and Alzheimer's Pathology in Animal Models of Alzheimer's Disease: A Systematic Review and Meta-Analysis

  2012cited by this paper
• The Murine Caecal MicroRNA Signature Depends on the Presence of the Endogenous Microbiota

  2011cited by this paper
• Docosahexaenoic Acid-Derived Neuroprotectin D1 Induces Neuronal Survival via Secretase- and PPARγ-Mediated Mechanisms in Alzheimer's Disease Models

  2011cited by this paper
• Region-specific distribution of β-amyloid peptide and cytokine expression in TgCRND8 mice.

  2011cited by this paper
• Rapid de‐esterification and loss of eicosapentaenoic acid from rat brain phospholipids: an intracerebroventricular study

  2011cited by this paper
• Docosahexaenoic Acid Reduces Amyloid β Production via Multiple Pleiotropic Mechanisms*

  2011cited by this paper
• Furan fatty acid as an anti-inflammatory component from the green-lipped mussel Perna canaliculus

  2011cited by this paper
• Docosahexaenoic Acid Therapy of Experimental Ischemic Stroke

  2010cited by this paper
• Ethyl-eicosapentaenoate modulates changes in neurochemistry and brain lipids induced by parkinsonian neurotoxin 1-methyl-4-phenylpyridinium in mouse brain slices.

  2010cited by this paper
• 17,18-epoxyeicosatetraenoic acid targets PPARγ and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung: role of soluble epoxide hydrolase.

  2010cited by this paper
• Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

  2008cited by this paper
• 5‐Lipoxygenase gene disruption reduces amyloid‐β pathology in a mouse model of Alzheimer's disease

  2008cited by this paper
• Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

  2008cited by this paper
• The vasodilator 17,18‐epoxyeicosatetraenoic acid targets the pore‐forming BK α channel subunit in rodents

  2007cited by this paper
• Inflammation and neurodegenerative diseases.

  2006cited by this paper
• Immunochemical and morphometric features of astrocyte reactivity vs. plaque location in Alzheimer's disease.

  2005cited by this paper
• A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease.

  2005cited by this paper
• Inflammatory mediator and beta-amyloid (25-35)-induced ceramide generation and iNOS expression are inhibited by vitamin E.

  2004cited by this paper
• Aminopyridazines inhibit-amyloid-induced glial activation and neuronal damage in vivo

  2004cited by this paper
• 12/15-lipoxygenase is increased in Alzheimer's disease: possible involvement in brain oxidative stress.

  2004cited by this paper
• Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease.

  2001cited by this paper
• Association of interleukin‐1 gene polymorphisms with Alzheimer's disease

  2000cited by this paper
• Inflammation, A beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration.

  1996cited by this paper
• Altered expression of transforming growth factor-beta in Alzheimer's disease

  1995cited by this paper
• Identification of Fc gamma RI, II and III on normal human brain ramified microglia and on microglia in senile plaques in Alzheimer's disease.

  1993cited by this paper
• Identification of FcγRI, II and III on normal human brain ramified microglia and on microglia in senile plaques in Alzheimer's disease

  1993cited by this paper
• Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer's disease.

  1990cited by this paper
• The formation of prostaglandins in the postmortem cerebral cortex of Alzheimer-type dementia patients

  1989cited by this paper
• Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.

  1989cited by this paper

• The role of fatty acids in neurodegenerative diseases: mechanistic insights and therapeutic strategies

  2025cites this paper
• The supplementation of a high dose of fish oil during pregnancy and lactation led to an elevation in Mfsd2a expression without any changes in docosahexaenoic acid levels in the retina of healthy 2-month-old mouse offspring

  2024cites this paper
• Genetically determined dietary habits and risk of Alzheimer’s disease: a Mendelian randomization study

  2024cites this paper
• The Impact of High-Dose Fish Oil Supplementation on Mfsd2a, Aqp4, and Amyloid-β Expression in Retinal Blood Vessels of 5xFAD Alzheimer’s Mouse Model

  2024cites this paper
• Unraveling the impact of Omega-3 polyunsaturated fatty acids on blood-brain barrier (BBB) integrity and glymphatic function.

  2023cites this paper
• Measuring brain docosahexaenoic acid turnover as a marker of metabolic consumption.

  2023cites this paper
• Maresin: Macrophage Mediator for Resolving Inflammation and Bridging Tissue Regeneration—A System-Based Preclinical Systematic Review

  2023cites this paper
• Specialized Pro-Resolving Mediators in Neuroinflammation: Overview of Studies and Perspectives of Clinical Applications

  2022cites this paper
• The high-dose fish oil supplementation increased Mfsd2a expression without altering DHA levels in the retina of healthy mice

  2022cites this paper
• Resolvin D1: A key endogenous inhibitor of neuroinflammation

  2022cites this paper
• Lipidomics of Bioactive Lipids in Alzheimer’s and Parkinson’s Diseases: Where Are We?

  2022cites this paper
• Role of Specialized Pro-resolving Mediators in Reducing Neuroinflammation in Neurodegenerative Disorders

  2022cites this paper
• Fatty acids as biomodulators of Piezo1 mediated glial mechanosensitivity in Alzheimer's disease.

  2022cites this paper
• Effects of safflower yellow on cholesterol levels in serum and brain tissue of APP/PS1 mice

  2021cites this paper
• Docosahexanoic acid signals through the Nrf2–Nqo1 pathway to maintain redox balance and promote neurite outgrowth

  2021cites this paper
• Lipid Peroxidation and Antioxidant Supplementation in Neurodegenerative Diseases: A Review of Human Studies

  2020cites this paper
• Environmental Signals on Microglial Function during Brain Development, Neuroplasticity, and Disease

  2020cites this paper
• Lipids Nutrients in Parkinson and Alzheimer’s Diseases: Cell Death and Cytoprotection

  2020cites this paper
• The effect of fish oil on social interaction memory in total sleep-deprived rats with respect to the hippocampal level of stathmin, TFEB, synaptophysin and LAMP-1 proteins.

  2020cites this paper
• Fish Oil and Primrose Oil Suppress the Progression of Alzheimer's Like Disease Induced by Aluminum in rats.

  2020cites this paper
• Dietary Fatty Acid Factors in Alzheimer’s Disease: A Review

  2020cites this paper
• Acute EPA-induced learning and memory impairment in mice is prevented by DHA

  2020cites this paper
• The effects of bioavailable omega-3 polyunsaturated fatty acids, delivered at bedtime, on brain function, sleep, cognition and mood in healthy adults

  2019cites this paper
• The effects of n-6 polyunsaturated fatty acid deprivation on the inflammatory gene response to lipopolysaccharide in the mouse hippocampus

  2019cites this paper
• Inflammation resolution and specialized pro-resolving lipid mediators in CNS diseases

  2019cites this paper
• The Effects of Doxorubicin-based Chemotherapy and Omega-3 Supplementation on Mouse Brain Lipids

  2019cites this paper
• Maternal Dietary Docosahexaenoic Acid Alters Lipid Peroxidation Products and (n-3)/(n-6) Fatty Acid Balance in Offspring Mice

  2019cites this paper
• The Formyl Peptide Receptor 2 Regulates Microglial Phenotype Through Immunometabolism: Implications for Alzheimer’s Disease

  2019influential citation
• Maternal supplementation with fish oil modulates inflammation-related MicroRNAs and genes in suckling lambs

  2019cites this paper
• Increased brain docosahexaenoic acid has no effect on the resolution of neuroinflammation following intracerebroventricular lipopolysaccharide injection

  2018cites this paper
• Short-Term Fish Oil Treatment Changes the Composition of Phospholipids While Not Affecting the Expression of Mfsd2a Omega-3 Transporter in the Brain and Liver of the 5xFAD Mouse Model of Alzheimer’s Disease

  2018cites this paper
• Food for Mood: Relevance of Nutritional Omega-3 Fatty Acids for Depression and Anxiety

  2018cites this paper
• Dietary omega-3 deficiency exacerbates inflammation and reveals spatial memory deficits in mice exposed to lipopolysaccharide during gestation.

  2018cites this paper